Company Illumina, Inc.

Equities

ILMN

US4523271090

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 01:29:24 2024-03-28 pm EDT 5-day change 1st Jan Change
137.7 USD -0.73% Intraday chart for Illumina, Inc. +0.05% -1.23%

Business Summary

Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows:

- product sales (84.1%): tools and instruments for sequencing, genotyping, genetic expression, etc.;

- sales of services (15.9%).

Net sales are distributed geographically as follows: the United States (52.4%), Americas (3.6%), Europe (25.3%), Asia/Pacific/Middle East/Africa (10.2%) and China/Taiwan/Hong Kong (8.5%).

Number of employees: 10,615

Sales per Business

USD in Million2022Weight2023Weight Delta
Core Illumina
98.5 %
4,553 99.3 % 4,438 98.5 % -2.53%
Grail
2.1 %
55 1.2 % 93 2.1 % +69.09%
Eliminations
-0.6 %
-24 -0.5 % -27 -0.6 % +12.50%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
52.4 %
2,290 50.0 % 2,359 52.4 % +3.01%
Europe
25.3 %
-- 1,140 25.3 % -
Asia-Pacific, Middle East and Africa
10.2 %
418 9.1 % 459 10.2 % +9.81%
Greater China
8.5 %
472 10.3 % 384 8.5 % -18.64%
Americas
3.6 %
189 4.1 % 162 3.6 % -14.29%

Managers

Managers TitleAgeSince
Chief Executive Officer 49 23-09-24
Director of Finance/CFO 52 19-09-22
Chief Tech/Sci/R&D Officer - 97-12-31
Chief Tech/Sci/R&D Officer 54 22-03-13
Chief Operating Officer 57 21-10-31
Investor Relations Contact - 21-11-30
Corporate Officer/Principal - -
Comptroller/Controller/Auditor 52 13-10-31
Corporate Officer/Principal - Jan. 04
Sales & Marketing 55 20-09-27

Members of the board

Members of the board TitleAgeSince
Director/Board Member 69 12-11-28
Chairman 60 23-06-01
Director/Board Member 64 17-01-26
Director/Board Member 57 23-06-01
Director/Board Member 63 16-07-27
Director/Board Member 58 17-11-30
Director/Board Member 63 19-02-04
Director/Board Member 67 16-01-27
Director/Board Member 38 23-05-24
Chief Executive Officer 49 23-09-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 198,900,000 158,455,920 ( 79.67 %) 40,000,000 ( 20.11 %) 79.67 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
11.44 %
18,178,513 11.44 % 2 542 M $
BlackRock Advisors LLC
6.409 %
10,183,833 6.409 % 1 424 M $
Edgewood Management LLC
4.329 %
6,878,495 4.329 % 962 M $
6,723,616 4.231 % 940 M $
Baillie Gifford & Co.
3.320 %
5,275,769 3.320 % 738 M $
Loomis, Sayles & Co. LP
2.785 %
4,424,688 2.785 % 619 M $
Janus Henderson Investors US LLC
2.771 %
4,402,380 2.771 % 616 M $
Eaton Vance Management
2.327 %
3,697,580 2.327 % 517 M $
Geode Capital Management LLC
2.287 %
3,634,176 2.287 % 508 M $
Wellington Management Co. LLP
2.038 %
3,239,021 2.038 % 453 M $

Company contact information

Illumina, Inc.

5200 Illumina Way

92122, San Diego

+858 202 4500

http://www.illumina.com
address Illumina, Inc.(ILMN)